7.02

0.29% +0.02

After Hours: 7.00 -0.02 -0.28%

ElectroCore Inc (ECOR)

Overview News Price History Financials Discussions Forecast Stock Split

ElectroCore Inc stock is currently priced at $7.02, with a 24-hour trading volume of 51,381. It has seen a +0.29% increased in the last 24 hours and a +16.61% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $6.75 pivot point. If it approaches the $7.42 resistance level, significant changes may occur.

Previous Close:

$7.00

Open:

$7.24

24h Volume:

51,381

Market Cap:

$42.14M

Revenue:

$16.03M

Net Income/Loss:

$-18.83M

P/E Ratio:

-1.4966

EPS:

-4.6906

Net Cash Flow:

$-14.87M

1W Performance:

+12.51%

1M Performance:

+16.61%

6M Performance:

+22.09%

1Y Performance:

+21.87%

1D Range:

$6.987

$7.362

52W Range:

$3.8285

$8.08

ElectroCore Inc Stock (ECOR) Company Profile

Name

ElectroCore Inc

Sector

Healthcare (1216)

Industry

Medical Devices (160)

Phone

973 290 0097

Address

200 Forge Way, Suite 205, Rockaway

Employee

Twitter

@electroCoreVNS

Next Earnings Date

2024-05-08

Latest SEC Filings

ECOR's Discussions on Twitter

ElectroCore Inc Stock (ECOR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-14-20	Upgrade	BTIG Research	Neutral → Buy
Nov-14-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-26-19	Resumed	Cantor Fitzgerald	Neutral
May-30-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-15-19	Downgrade	BTIG Research	Buy → Neutral
May-09-19	Initiated	Noble Capital Markets	Outperform
Sep-21-18	Initiated	Cantor Fitzgerald	Overweight

View All

ElectroCore Inc Stock (ECOR) Latest News

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire Inc.

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

GlobeNewswire Inc.

ElectroCore Inc Stock (ECOR) Financials Data

ElectroCore Inc (ECOR) Revenue 2024

ECOR reported a revenue (TTM) of $16.03 million for the quarter ending December 31, 2023, a +86.57% rise year-over-year.

ElectroCore Inc (ECOR) Net Income 2024

ECOR net income (TTM) was -$18.83 million for the quarter ending December 31, 2023, a +15.02% increase year-over-year.

ElectroCore Inc (ECOR) Cash Flow 2024

ECOR recorded a free cash flow (TTM) of -$14.87 million for the quarter ending December 31, 2023, a +10.64% increase year-over-year.

ElectroCore Inc (ECOR) Earnings per Share 2024

ECOR earnings per share (TTM) was -$3.50 for the quarter ending December 31, 2023, a +27.39% growth year-over-year.

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.